Oncternal Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2016 - 2020
Cash & Equivalents	117.32	99.59	102.83	155.58	42.3	45.9	Upgrade
Short-Term Investments	446.03	617.99	374.54	268.97	154.67	81.74	Upgrade
Cash & Short-Term Investments	563.36	717.58	477.37	424.55	196.97	127.64	Upgrade
Cash Growth	-1.40%	50.32%	12.44%	115.55%	54.31%	375.47%	Upgrade
Receivables	-	-	0.1	0.1	0.45	-	Upgrade
Prepaid Expenses	15.39	20.88	9.01	6.52	2.65	1.97	Upgrade
Other Current Assets	-	-	-	-	0.1	-	Upgrade
Total Current Assets	578.75	738.46	486.48	431.17	200.16	129.61	Upgrade
Property, Plant & Equipment	3.07	3.44	3.34	2.94	2.06	0.79	Upgrade
Other Long-Term Assets	0.51	0.5	0.6	0.98	1.49	0.86	Upgrade
Total Assets	582.32	742.4	490.42	435.09	203.71	131.26	Upgrade
Accounts Payable	8.52	2.14	2.24	14.23	2.33	0.67	Upgrade
Accrued Expenses	34.79	44.83	23.17	18.11	10.4	9.06	Upgrade
Current Portion of Long-Term Debt	8.44	-	-	-	-	-	Upgrade
Current Portion of Leases	0.55	0.51	0.84	0.61	0.52	0.46	Upgrade
Current Unearned Revenue	0.29	0.29	0.29	0.29	0.29	0.3	Upgrade
Other Current Liabilities	-	0.1	0.1	0.1	0.1	0.19	Upgrade
Total Current Liabilities	52.59	47.87	26.64	33.35	13.64	10.67	Upgrade
Long-Term Debt	12.35	20.58	20.21	4.65	-	-	Upgrade
Long-Term Leases	1.74	2.02	0.99	-	-	-	Upgrade
Long-Term Unearned Revenue	0.14	0.28	0.57	0.86	1.15	-	Upgrade
Other Long-Term Liabilities	0.34	-	-	1.17	1.21	0.54	Upgrade
Total Liabilities	67.16	70.76	48.4	40.03	15.99	11.22	Upgrade
Common Stock	0.82	0.81	0.54	0.41	0.24	0.04	Upgrade
Additional Paid-In Capital	1,509	1,478	960.54	741.07	412.1	218.09	Upgrade
Retained Earnings	-1,184	-995.86	-725.91	-488.17	-358.3	-278.89	Upgrade
Comprehensive Income & Other	0.07	-0.01	0.34	-0.39	-0.16	-0.01	Upgrade
Total Common Equity	326.28	482.75	235.51	252.92	53.88	-60.76	Upgrade
Shareholders' Equity	515.17	671.64	442.02	395.06	187.72	120.04	Upgrade
Total Liabilities & Equity	582.32	742.4	490.42	435.09	203.71	131.26	Upgrade
Total Debt	23.08	23.12	22.04	5.26	0.52	0.46	Upgrade
Net Cash (Debt)	540.28	694.47	455.33	419.29	196.45	127.18	Upgrade
Net Cash Growth	-1.55%	52.52%	8.60%	113.44%	54.46%	585.96%	Upgrade
Net Cash Per Share	6.98	10.23	10.17	13.07	16.48	35.76	Upgrade
Filing Date Shares Outstanding	81.66	81.48	62.77	42.9	25.91	7.23	Upgrade
Total Common Shares Outstanding	81.65	80.99	53.99	41.31	23.92	4.23	Upgrade
Working Capital	526.17	690.59	459.84	397.82	186.53	118.94	Upgrade
Book Value Per Share	4.00	5.96	4.36	6.12	2.25	-14.36	Upgrade
Tangible Book Value	326.28	482.75	235.51	252.92	53.88	-60.76	Upgrade
Tangible Book Value Per Share	4.00	5.96	4.36	6.12	2.25	-14.36	Upgrade
Machinery	-	2.25	2.05	2.22	1.4	3.01	Upgrade
Leasehold Improvements	-	0.25	0.67	1.11	0.75	0.74	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.